CB Financial Services, Inc. Announces Quarterly Cash Dividend
Get Alerts CBFV Hot Sheet
Join SI Premium – FREE
CARMICHAELS, Pa., May 16, 2018 (GLOBE NEWSWIRE) -- CB Financial Services, Inc. (the “Company”) (NASDAQ: CBFV), the holding company for Community Bank, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per outstanding share of common stock. The dividend will be paid on or about June 18, 2018 to stockholders of record as of the close of business on June 8, 2018.
“We are pleased to continue the $0.22 per share dividend in the second quarter of 2018,” commented Barron P. McCune, Jr., Vice Chairman and Chief Executive Officer. “Our strong capital position along with core loan and deposit growth allows us to continue to tell our story.”
About CB Financial Services, Inc.
CB Financial Services, Inc. is the bank holding company for Community Bank, a Pennsylvania-chartered commercial bank. Community Bank operates sixteen offices in Greene, Allegheny, Washington, Fayette, and Westmoreland Counties in southwestern Pennsylvania, seven offices in Brooke, Marshall, Ohio, Upshur and Wetzel Counties in West Virginia, and one office in Belmont County in Ohio. Community Bank offers a broad array of retail and commercial lending and deposit services and provides commercial and personal insurance brokerage services through Exchange Underwriters, Inc., its wholly owned subsidiary.
For more information about CB Financial Services, Inc. and Community Bank, visit our website at www.communitybank.tv.
Contact: Barron P. McCune, Jr.Vice Chairman and Chief Executive OfficerPhone: (724) 225-2400Fax: (724) 225-4903
Source: CB Financial Services, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pepe’s 19% Surge Meets Fartcoin’s Breakout Signal, While Apeing Draws Attention as the New Meme Coin 2026 With 100x Gains
- UAB “Atsinaujinančios energetikos investicijos” Starts Second Tranche Offering Of Notes Under The EUR 25 million Bonds Programme; The First Tranche Final Terms Of Notes Were Adjusted
- Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Barron's, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share